Pure-Play Australian Technology Exposure in One ETF: BetaShares S&P/ASX Australian Technology ETF (ASX:ATEC) Under Review

Sonal Goyal

21 September 2026 03:29 AM AEST

Pure-Play Australian Technology Exposure in One ETF: BetaShares S&P/ASX Australian Technology ETF (ASX:ATEC) Under Review

Image Source: Shutterstock

You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research. Learn more

Start Your Free Trial Now!

Key Highlights

• Tracks the S&P/ASX All Technology index with 42 holdings; fund size of $554.23 million

• Management fee of 0.48% per annum; 52-week range of $18.66 to $33.24, a spread of approximately 78% from trough to peak

• Sector allocation: Technology 58.70%, Communication Services 17.52%, Healthcare 12.85%, Financial Services 10.84%

The BetaShares S&P/ASX Australian Technology ETF (ASX:ATEC) tracks the S&P/ASX All Technology Total Return AUD Index, providing investors with concentrated exposure to the technology-oriented segment of the Australian equities market. Listed on 5 March 2020, the fund has grown to $554.23 million in Assets with 26.34 million units outstanding. ATEC is the primary vehicle for investors seeking single-sector, pure-play Australian technology exposure within an exchange-traded format, covering companies across technology, communications, healthcare IT, and financial technology that are classified under the S&P/ASX All Technology framework.

Index Composition and Sector Definition

The S&P/ASX All Technology Index applies a broad definition of "technology" that extends beyond purely software and hardware companies to include communications services, healthcare technology, and financial services businesses with significant technology characteristics. The fund's sector breakdown confirms this: Technology at 58.70%, Communication Services at 17.52%, Healthcare at 12.85%, and Financial Services at 10.84%. The healthcare component at 12.85% is largely driven by Pro Medicus, a medical imaging software company that is classified within the technology-aligned healthcare space. This broad sector definition means ATEC is not purely a software or hardware play but rather a broader digitally-oriented Equity basket. The fund employs full replication, holding all 42 index constituents in proportion to their index weights.

Portfolio Composition and Concentration

ATEC holds 42 companies, with the top 10 positions accounting for 72.04% of the fund — a very high concentration level reflecting the relatively small number of qualifying technology companies on the ASX and the market-cap weighting that concentrates assets in the largest names. The ten largest positions are: Computershare at 10.33%, Xero at 9.19%, Pro Medicus at 9.05%, NEXTDC at 8.91%, Car Group at 7.84%, Technology One at 7.21%, WiseTech Global at 5.61%, REA Group at 5.59%, Codan at 4.19%, and Megaport at 4.08%. The top three holdings alone — Computershare, Xero, and Pro Medicus — account for approximately 28.57% of the fund. Geographic exposure is 92.41% Australian, with the United States at 7.30% and New Zealand at 0.29%, the US component reflecting the ASX-listed entities with significant US operations or dual-listed structures.

Distribution Profile

ATEC distributes income semi-annually. Distribution amounts have been highly variable: $0.352 per unit in July 2026, $0.060 in January 2026, $0.621 in July 2025, $0.049 in January 2025, and $0.060 in July 2024. The large gap between January and July distributions in each year reflects the seasonal concentration of Dividend payments from the underlying equity holdings in the half-year July reporting period. The annualised Yield of 1.96% is low relative to bond-focused ETFs, consistent with the growth-orientation of the technology sector where companies typically retain Earnings for reinvestment rather than distributing high dividend yields.

Risk Metrics and Performance

ATEC carries a Standard Deviation of 23.28, the highest of any ETF in this broader analysis, reflecting the elevated Volatility of the Australian technology sector. The Beta of 0.78 is below 1.0, which may appear counterintuitive for a high-volatility product but reflects the correlation characteristics of the Australian technology sector relative to the broader Australian equities market rather than to a technology-specific benchmark. The 52-week range of $18.66 to $33.24 — a spread of approximately 78% from trough to peak — is by far the widest price range of any product in this analysis and underscores the scale of price swings that technology sector investors must accept.

FAQs

Q: What companies does ATEC hold?

A: ATEC holds 42 ASX-listed companies classified under the S&P/ASX All Technology Index, including Computershare (10.33%), Xero (9.19%), Pro Medicus (9.05%), NEXTDC (8.91%), Car Group (7.84%), Technology One (7.21%), WiseTech Global (5.61%), and REA Group (5.59%) as the largest positions.

Q: How does ATEC's distribution compare to bond ETFs?

A: ATEC's annualised yield of approximately 1.96% is materially lower than bond ETFs (3.04%-5.04%), consistent with the growth orientation of technology companies that typically reinvest earnings rather than paying large dividends. ATEC's return driver is primarily capital appreciation rather than income.

Q: How often does ATEC pay distributions?

A: ATEC distributes semi-annually, in January and July. Distribution amounts are highly variable — ranging from $0.049 to $0.621 per unit in recent periods — reflecting the dividend patterns of the underlying equity holdings.

Q: What is the management fee for ATEC?

A: The management fee is 0.48% per annum, which is moderate for a single-sector technology ETF with full replication of 42 index constituents.

Download Free Report – Explore 3 Stock Ideas & Industry Insights

Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.

All investments involve risk—consider independent advice before making any investment decisions.

View 3 Research Reports

Disclaimer:

This article (“Article”) has been prepared by Kalkine Pty Limited (ABN 34 154 808 312) (Australian financial services licence number 425376) (“Kalkine”) and its related bodies corporate who are authorised to provide general financial product advice. Kalkine.com.au and its associated pages are published by Kalkine.

Any information/advice provided in this article is general in nature and does not take into account your objectives, financial situation or needs. You should therefore consider whether the information is appropriate for your objectives, financial situation and needs before acting upon it.

There may be a Product Disclosure Statement, Information Memorandum or other offer document (“Offer Document”) for the securities or other financial products referred to in Kalkine articles. You should obtain a copy of the Offer Document and consider it before making any decision about whether to acquire the security or financial product.

Kalkine strongly recommends that you seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) before acting on any advice/information in this Article or on the Kalkine website. Not all investments are appropriate for all people.

The information in this Article and on Kalkine website has been prepared from a wide variety of sources, which Kalkine, to the best of its knowledge and belief, considers accurate. Kalkine has made every effort to ensure the reliability of the information contained in its articles (including this Article), newsletters and websites. All information represents our views at the date of publication and may change without notice.

The information in this Article does not constitute an offer to sell securities or other financial products or a solicitation of an offer to buy securities or other financial products.

Kalkine does not issue, sell or deal in any financial products.

This Article may contain information on past performance of particular investments. Please note past performance is neither an indicator nor a guarantee of future performance.

To the extent permitted by law, and excluding any dishonesty or gross negligence by Kalkine, Kalkine disclaims and excludes all liability for any direct, indirect, implied, punitive, special, incidental or other consequential loss or damage arising from the use of or reliance on this Article, the Kalkine website and any information published on the Kalkine website without any warranties or representations by Kalkine to you. To the extent the law prohibits or limits this exclusion, Kalkine limits its liability to the resupply of services.

Please also read our Terms & Conditions and Financial Services Guide for further information.

Employees and/or associates of Kalkine and its related entities may hold interests in the securities or other financial products covered in this Article or on the Kalkine website. Any such employees and associates are required to comply with certain safeguards, procedures and disclosures as required by law.

Some of the images/music that may be used in the Article are copyright to their respective owner(s). Kalkine does not claim ownership of any of the pictures displayed/music used in the Article unless stated otherwise. The images/music that may be used in the Article are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Kalkine Media Pty Ltd, an affiliate of Kalkine Pty Ltd, may have received, or be entitled to receive, financial consideration in connection with providing information about certain entity(s) covered on its website.